title: Guidelines for monitoring of anthracycline cardiomyopathy: a rebuttal.
authors.forename: L J
authors.initials: LJ
authors.lastname: Steinherz
authors.forename: T
authors.initials: T
authors.lastname: Graham
authors.forename: R
authors.initials: R
authors.lastname: Hurwitz
authors.forename: H M
authors.initials: HM
authors.lastname: Sondheimer
authors.forename: E M
authors.initials: EM
authors.lastname: Schaffer
authors.forename: R G
authors.initials: RG
authors.lastname: Schwartz
authors.forename: G
authors.initials: G
authors.lastname: Sandor
authors.forename: L
authors.initials: L
authors.lastname: Benson
authors.forename: R
authors.initials: R
authors.lastname: Williams
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D006321:Heart / Q000187:drug effects; D006334:Heart Function Tests; D006801:Humans; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000903:Antibiotics, Antineoplastic